ACTRN12619000887178招募中4 期
Effects of Empagliflozin on Autonomic Nervous System Function and Cardiac Function in Patients with Type 2 Diabetes.
适应症
试验速览
- 阶段
- 4 期
- 状态
- 招募中
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 18 Years 至 75 Years（—）
- 性别
- All
入选标准
- •Adults with established Type 2 diabetes > 12 months on any anti-hyperglycaemic agents except for SGLT-2 inhibitors
- •- HbA1c 7.1-10.0%
- •- Estimated glomerular filtration rate (e-GFR) > 45 ml/min
排除标准
- •- History of sodium glucose transporter-2 (SGLT2) inhibitor treatment in the past 3 months or intolerance
- •- Age > 75 years
- •- Known heart failure or established cardiac disease
- •- Treatment with beta blockers or centrally acting sympathetic blockers
- •- Unable to perform moderate cycloergometric exercise
- •- Chronic kidney disease stage IIIB or above (e-GFR <45)
- •- History of recurrent genital infections and Urinary Tract Infections
- •- Hypoglycaemia requiring third party assistance in the previous 3 months
- •euglycaemic diabetic ketoacidosis in the previous 6 months
研究者
相似试验
已完成
3 期
Effects of empagliflozin in diabetes treatmentIRCT20191126045505N1Bojnourd University of Medical Sciences100
已完成
4 期
EMPYREAN StudyJPRN-jRCTs031180043Kuwahara Kouichiro113
尚未招募
2 期
Assessment of extra-renal effects of SGLT2-inhibitors in anuric haemodialysis patients using microneurographyACTRN12623001237673Dobney Hypertension Centre20
已完成
不适用
The effect of empagliflozin on diuresis and neurohumoral factors in the patients with decompensated heart failure and diabetes mellitus: pilot studydecompensated heaat failure type 2 diabetes mellitusJPRN-UMIN000027431Department of Cardiology, National Hospital Organization Yokohama Medical Center15
尚未招募
3 期
Evaluation of the effect of Empagliflozin on the severity of heart failure symptoms and echocardiography parameters in patients with congenital heart diseases with left-to-right shuntIRCT20120520009801N11Mashhad University of Medical Sciences44